Overview:

High-intensity electromagnetic field therapy is reshaping the approach to pelvic-floor rehabilitation by offering a safe, comfortable, and non-invasive alternative to surgery or electrostimulation. The EMStrong® Pelvic Therapy Chair applies High-Intensity Concentrated Magnetic Muscle Training (HICMMT) technology to re-educate and strengthen pelvic-floor muscles. This helps reduce urinary incontinence, enhance sexual wellness, and improve overall quality of life—all without discomfort or downtime.

About the Device:

The EMStrong® system is a professional-grade, FDA-cleared and CE-certified device for powered muscle stimulation.
It generates thousands of deep, supra-maximal contractions during a 30-minute session, producing muscle engagement far beyond what voluntary exercise can achieve.

Treatment Modes:

• U1 – Urinary Incontinence Mode: strengthens bladder-control muscles to improve continence.
• U2 – Sexual Wellness Mode: enhances pelvic muscle tone, circulation, and neuromuscular control to improve intimate function.

Patients remain fully clothed throughout each session, seated comfortably while electromagnetic energy activates the pelvic muscles in a hands-free and painless process.

Science Behind the Technology:

Peer-reviewed research supports the effectiveness of high-intensity electromagnetic therapy for pelvic-floor strengthening and incontinence management.
A study by Silantyeva et al. (2020) published in Female Pelvic Medicine & Reconstructive Surgery compared electromagnetic stimulation with electrostimulation for women experiencing pelvic-floor weakness. The research demonstrated significant anatomical and functional improvements with high-intensity electromagnetic therapy.

While that paper evaluated a different manufacturer’s system, it validates the same scientific principle used by the EMStrong® Chair through its proprietary HICMMT technology.

Clinical Study Summary (Silantyeva et al.):

• Participants: 95 postpartum women aged 18 to 45 years
• Protocol: 10 sessions × 28 minutes each over 4 weeks
• Assessment: 3-D ultrasound imaging and Pelvic Floor Disability Index-20 (PFDI-20) questionnaire
  
  

Key Findings:

• 52 % mean improvement in PFDI-20 scores vs 18 % for electrostimulation
• Up to 44 % reduction in urinary-leakage and laxity symptoms
• Statistically significant (p < 0.05) enhancement in pelvic-floor muscle structure
• No pain or adverse events reported

Conclusion:

Evidence from independent studies supports the clinical value of high-intensity electromagnetic stimulation for restoring pelvic-floor strength and improving continence.
The EMStrong® Pelvic Therapy Chair delivers these benefits using Rejuva Fresh’s advanced HICMMT technology in an operator-independent, hands-free format that is comfortable, efficient, and clinically effective.

Typical results include:

• Noticeable reduction in urinary leakage
• Improved pelvic-floor tone and muscle control
• Enhanced sexual wellness and satisfaction
• Better posture, confidence, and quality of life

References:

1. Silantyeva E, Zarkovic D, Astafeva E et al. Female Pelvic Med Reconstr Surg. 2020; 27(4): 269–273. Peer-reviewed study demonstrating the efficacy of high-intensity electromagnetic therapy for pelvic-floor rehabilitation.
   
   
2. FDA Registration Database – Rejuva Fresh LLC (EMStrong and EMShape Neo-X Devices, Product Code NGX / K231318).
   
   

Rejuva Fresh LLC. EMStrong® Pelvic Therapy Chair Product Data Sheet. 2025